C

Bio-Rad Laboratories, Inc. BIO

$361.86 $1.360.38% NYSE
Recommendation
Dividend Power Score
Day's Range
$359.83$367.93
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

BIO Rating

Reward
Risk

BIO Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

BIO Company Overview

Bio-Rad Laboratories, Inc. is a global life science and clinical diagnostics company that develops, manufactures, and markets analytical instruments, reagents, consumables, and software used for research, biopharmaceutical production, and clinical diagnostics. The company operates primarily in the life science research and clinical diagnostics industries, serving academic institutions, pharmaceutical and biotechnology companies, hospitals, reference laboratories, and public health organizations. Its core revenue drivers are laboratory instruments, assay systems, reagents, and recurring consumables used in regulated and research environments.

Founded in 1952 by David Schwartz and Alice Schwartz, Bio-Rad began as a supplier of scientific instruments for biochemical research and steadily expanded through internal development and acquisitions. Over time, the company built a diversified portfolio spanning molecular biology, cell biology, immunology, and diagnostic testing, establishing a reputation for quality, regulatory compliance, and long-standing customer relationships. Bio-Rad is recognized for its durable installed base of instruments, which supports recurring revenue from reagents and consumables.

Data compiled by narrative technology. May contain errors.
Sector

BIO Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

BIO Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

BIO Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

BIO Price History

Loading...
52-Week Range78% of range
Current
$361.86
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

BIO Valuation

Market Cap
Market Cap Rank
#2,507
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

BIO Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

BIO Corporate Info

Phone Number
510 724 7000
Address
1000 Alfred Nobel Drive
Hercules, CA 94547
Country
Year Founded

BIO Filings

Filing Date
Tuesday, August 4, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Oct 26 and 30 (est)

BIO Headlines

10/6/2026 - Zacks Investment Research